INGN Inogen Inc

NEUTRAL Impact: 6/10 8-K
Horizon weeks Filed Apr 6, 2026 Processed 2mo ago SEC 0001193125-26-143703
8-K material event: Items 1.01
Latest settled — T+20d
INGN ▲ +2.50% at T+20d
NEUTRAL call ✓ call won +2.50% · α vs SPY -7.28% · entry $6.80 → $6.97
Next anchor: T+60d in 21d
Last close $6.06 (close Jun 8) · -10.88% from $6.80 entry
Entry anchored
Apr 6, 04:01 PM ET
via Databento tick
T+1d
-1.91%
call -1.91% · α -4.45%
$6.67
settled 2mo ago
T+5d
-6.76%
call -6.76% · α -12.09%
$6.34
settled 8w ago
T+20d
+2.50%
call +2.50% · α -7.28%
$6.97
settled 5w ago
T+60d
—
call — · α —
—
in 21d

Price Chart

Loading chart...

Executive Summary

Inogen Inc. has entered into a cooperation agreement with activist investor Kent Lake Partners, resulting in the appointment of Vafa Jamali to the board as an independent director. This follows shortly after the departure of another executive, indicating a forced management transition driven by investor pressure.

Actionable Insight

Traders should monitor for further changes in board composition or strategy, as activist involvement often leads to additional governance changes. The appointment of an experienced medtech executive suggests a focus on operational improvements.

Key Facts

  • Inogen entered a cooperation agreement with Kent Lake Partners LP, Kent Lake PR LLC, and Benjamin Natter.
  • Vafa Jamali was appointed to the board as a Class I director and to the Audit and Compliance Committees.
  • The agreement includes a voting commitment from the investor parties to support board recommendations and customary standstill provisions.
  • This board appointment follows within 14 days of a prior executive departure, indicating a forced management transition.
  • The company will reimburse the investor parties for up to $7,500 in legal and related expenses.

Financial Impact

The financial impact is minimal, limited to a $7,500 reimbursement for investor expenses and standard director compensation for the new appointee.

expensescompensation

Risk Factors

  • Potential for further activist demands or board changes
  • Possible strategic shifts that could disrupt current operations

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-143703
Document: ingn-20260406.htm0001193125-26-143703
Document: ingn-ex99_1.htm0001193125-26-143703
Document: 0001193125-26-143703-index-headers.html0001193125-26-143703
Document: 0001193125-26-143703-index.html0001193125-26-143703
Document: 0001193125-26-143703.txt0001193125-26-143703
2 reports for INGN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for INGN — sortable, filterable
Type Now
Apr 6, 2026
9w ago
8-K
NEUTRAL ★ 6/10
$6.80 $6.97▲ +2.50%▼ −7.28%$6.06 (−10.88%)
Feb 24, 2026
15w ago
8-K
BULLISH ★ 7/10
$6.01 $6.42▲ +6.82%▲ +12.06%$6.06 (+0.83%)
Showing 2 of 2

US Market Status

Market Closed — Opens in 7h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access